Like other new tools in the drug discovery process, automation, implemented properly, can generate the insight necessary to drive the pharmaceutical business forward.

While other common types of contamination are usually quickly identified and/or treated, mycoplasma contamination often provides no clear symptoms but can wreak havok on assay results.

The world's leading network scientists will share their latest research at a conference hosted by the New York Hall of Science on May 20 - 25.

NetSci 2007: International Workshop and Conference on Network Scien

IMS Health has reported that U.S. prescription drug sales grew 8.3 percent to $274.9 billion in 2006.

Growth was fueled by the Medicare Part D prescription benefit, the increased utilization of generics within ne

A growing number of scientists are working for firms designing software that models chemical and physical processes.

Mystic Pharmaceuticals Inc. today announced expansion plans for its Cedar Park, Texas R&D center to include clinical manufacturing operations for ophthalmic and intranasal drug delivery systems and pharmaceutical products under deve

America's pharmaceutical and biotechnology research companies set a new record for biopharmaceutical research spending last year with an investment of $55.2 billion to develop new medicines and vaccines, according to a new study. <

Nanofabrication could become relatively easy and cheap by using a 'bottom up' integrated assembly, Michael J. Heller said at the recent LabAutomoation 2007 conference.

Heller, co-founder of Nanogen and professor

The FDA has increased its focus on modernizing the regulation of pharmaceutical manufacturing and drug product quality. As a result, innovative pharmaceutical companies are re-examining whether traditional drug development and commercialization processes are sufficient.